Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04855929
Title A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients With Advanced Cancer and Multiple Myeloma. (ANV419-001)
Acronym ANV419-001
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Anaveon AG
Age Groups: adult | senior
Covered Countries GBR | ESP

No variant requirements are available.